Samiksha Jaiswal (Editor)

Anistreplase

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Trade names
  
Eminase

Biological half-life
  
90 minutes

DrugBank
  
DB00029

CAS ID
  
81669-57-0

ATC code
  
B01AD03 (WHO)

CAS Number
  
81669-57-0

Molar mass
  
131 million g/mol

AHFS/Drugs.com
  
Micromedex Detailed Consumer Information

Anistreplase is a thrombolytic drug.

Anistreplase has been developed by Beecham as Eminase. It is also known as anisoylated plasminogen streptokinase activator complex (APSAC)

Mechanism

It is a complex of purified human plasminogen and bacterial streptokinase that has been acylated to protect the enzyme's active site. When the drug is administered, the acyl group gets hydrolyzed, thereby freeing the activator complex. It converts plasminogen to plasmin, which in turn degrades fibrin (blood clots) to fibrin split products.

References

Anistreplase Wikipedia